CASP3 and prostate carcinoma: Another experiment demonstrated that low amounts of resveratrol (32) trigger death in the androgen-resistant prostate cancer DU-145 cell line; this is possibly an apoptotic response involving increased CASP3 activity via HSPA8/HSP70 [316].